After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
uniQure N.V. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of uniQure N.V. is $221.83M. A total of 0.7 million shares were traded on the day, compared to an average of 944.17K shares.
In the most recent transaction, Kapusta Matthew C sold 27,904 shares of QURE for 6.35 per share on Feb 26 ’24. After the transaction, the CEO, Managing Director now owns 440,839 company shares. In a previous transaction on Feb 26 ’24, KLEMT CHRISTIAN sold 15,906 shares at 6.38 per share. QURE shares that Chief Financial Officer owns now total 116,948.
Among the insiders who sold shares, CALOZ PIERRE disposed of 9,455 shares on Feb 26 ’24 at a per-share price of $6.47. This resulted in the Chief Operating Officer holding 85,643 shares of QURE after the transaction. In another insider transaction, Dolmetsch Ricardo sold 5,841 shares at $7.46 per share on Sep 18 ’23. Company shares held by the President, R&D now total 163,404.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, QURE has a high of $22.48 and a low of $4.25.
As of this writing, QURE has an earnings estimate of -$1.28 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.9 per share and a lower estimate of -$1.64. The company reported an EPS of -$1.63 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. QURE’s latest balance sheet shows that the firm has $556.26M in Cash & Short Term Investments as of fiscal 2021. There were $135.72M in debt and $36.76M in liabilities at the time. Its Book Value Per Share was $4.34, while its Total Shareholder’s Equity was $595.78M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for QURE is Buy with a score of 4.43.
